Strategic Science Leader for Pharma & Biotech Partnerships

Tempus AI, Inc.; Chicago (IL); Vor Ort; USD 178.000 - 264.000; Vollzeit

Benefits dieser Stelle

Incentive compensation

Restricted stock units

Zusammenfassung

Tempus AI, Inc. seeks a visionary Science Strategy Leader to drive scientific strategy, executive engagement, and cross-functional execution across pharma and biotech partnerships.

This senior role bridges science, portfolio strategy, and business impact to deliver differentiated value and accelerate drug development. Reporting to the Head of Life Science, this role leads JSC governance, integrates real-world data and multimodal insights, and scales strategic programs across accounts, with a

Qualifikationen

• 10+ years in pharma/biotech with experience in research, clinical development, and commercial strategy.
• Proven crossfunctional leadership in a matrix environment with global portfolio oversight.
• Expertise in data-driven clinical innovation and multimodal modalities integration.

Aufgaben

• Serve as the executive scientific lead for strategic Pharma/Biotech partnerships and JSCs.
• Lead cross-functional alignment and knowledge sharing across accounts and teams.
• Drive innovation in clinical development using real-world and multimodal evidence.
• Identify expansion opportunities by translating science into new collaborations.

Kenntnisse

Executive leadership

Data-driven clinical innovation

Cross-functional collaboration

Strategic engagement with pharma/biote

Multimodal data integration

Ausbildung

Advanced degree (PhD, MD, PharmD, or equivalent)

Jobbeschreibung

Tempus AI, Inc. seeks a visionary Science Strategy Leader to drive scientific strategy, executive engagement, and cross-functional execution across pharma and biotech partnerships.

This senior role bridges science, portfolio strategy, and business impact to deliver differentiated value and accelerate drug development. Reporting to the Head of Life Science, this role leads JSC governance, integrates real-world data and multimodal insights, and scales strategic programs across accounts, with a